Essentialis, Inc.
Quick facts
Phase 3 pipeline
- DCCR · Oncology
DCCR is a small molecule that inhibits the activity of the CDK8 protein.
Phase 2 pipeline
- Diazoxide Choline Controlled-Release Tablet · Cardiovascular
Potassium channel blocker
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: